158 related articles for article (PubMed ID: 35491999)
1. Obesity, Galectin-3, and Incident Heart Failure: The ARIC Study.
Florido R; Kwak L; Echouffo-Tcheugui JB; Zhang S; Michos ED; Nambi V; Goldberg RB; Hoogeveen RC; Lazo M; Gerstenblith G; Post WS; Blumenthal RS; Coresh J; Folsom AR; Selvin E; Ballantyne C; Ndumele CE
J Am Heart Assoc; 2022 May; 11(9):e023238. PubMed ID: 35491999
[TBL] [Abstract][Full Text] [Related]
2. Galectin-3, Metabolic Risk, and Incident Heart Failure: The ARIC Study.
Echouffo-Tcheugui JB; Zhang S; Florido R; Pankow JS; Michos ED; Goldberg RB; Nambi V; Gerstenblith G; Post WS; Blumenthal RS; Ballantyne CM; Coresh J; Selvin E; Ndumele CE
J Am Heart Assoc; 2024 Mar; 13(6):e031607. PubMed ID: 38471823
[TBL] [Abstract][Full Text] [Related]
3. Levels and Change in Galectin-3 and Association With Cardiovascular Events: The ARIC Study.
Aguilar D; Sun C; Hoogeveen RC; Nambi V; Selvin E; Matsushita K; Saeed A; McEvoy JW; Shah AM; Solomon SD; Boerwinkle E; Ballantyne CM
J Am Heart Assoc; 2020 Jul; 9(13):e015405. PubMed ID: 32573308
[TBL] [Abstract][Full Text] [Related]
4. Galectin-3 and Risk of Heart Failure and Death in Blacks and Whites.
McEvoy JW; Chen Y; Halushka MK; Christenson E; Ballantyne CM; Blumenthal RS; Christenson RH; Selvin E
J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27178204
[TBL] [Abstract][Full Text] [Related]
5. Galectin-3 and incidence of atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) study.
Fashanu OE; Norby FL; Aguilar D; Ballantyne CM; Hoogeveen RC; Chen LY; Soliman EZ; Alonso A; Folsom AR
Am Heart J; 2017 Oct; 192():19-25. PubMed ID: 28938960
[TBL] [Abstract][Full Text] [Related]
6. Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community.
Ho JE; Liu C; Lyass A; Courchesne P; Pencina MJ; Vasan RS; Larson MG; Levy D
J Am Coll Cardiol; 2012 Oct; 60(14):1249-56. PubMed ID: 22939561
[TBL] [Abstract][Full Text] [Related]
7. Association of Left Ventricular Systolic Function With Incident Heart Failure in Late Life.
Reimer Jensen AM; Zierath R; Claggett B; Skali H; Solomon SD; Matsushita K; Konety S; Butler K; Kitzman DW; Biering-Sørensen T; Shah AM
JAMA Cardiol; 2021 May; 6(5):509-520. PubMed ID: 33729428
[TBL] [Abstract][Full Text] [Related]
8. N-Terminal Pro-Brain Natriuretic Peptide and Heart Failure Risk Among Individuals With and Without Obesity: The Atherosclerosis Risk in Communities (ARIC) Study.
Ndumele CE; Matsushita K; Sang Y; Lazo M; Agarwal SK; Nambi V; Deswal A; Blumenthal RS; Ballantyne CM; Coresh J; Selvin E
Circulation; 2016 Feb; 133(7):631-8. PubMed ID: 26746175
[TBL] [Abstract][Full Text] [Related]
9. Diabetes Status Modifies the Association Between Different Measures of Obesity and Heart Failure Risk Among Older Adults: A Pooled Analysis of Community-Based NHLBI Cohorts.
Patel KV; Segar MW; Lavie CJ; Kondamudi N; Neeland IJ; Almandoz JP; Martin CK; Carbone S; Butler J; Powell-Wiley TM; Pandey A
Circulation; 2022 Jan; 145(4):268-278. PubMed ID: 34860539
[TBL] [Abstract][Full Text] [Related]
10. Galectin-3 and risk of ischaemic stroke: Reasons for Geographic and Racial Differences in Stroke cohort.
Arora P; Agarwal Z; Venkatraman A; Callas P; Kissela BM; Jenny NS; Judd SE; Zakai NA; Cushman M
Eur J Neurol; 2017 Dec; 24(12):1464-1470. PubMed ID: 28872212
[TBL] [Abstract][Full Text] [Related]
11. Myocardial Injury, Obesity, and the Obesity Paradox: The ARIC Study.
Pokharel Y; Sun W; Virani SS; Nambi V; Hoogeveen RC; Chang PP; Ndumele CE; Solomon SD; Bozkurt B; Selvin E; Ballantyne CM; Deswal A
JACC Heart Fail; 2017 Jan; 5(1):56-63. PubMed ID: 28017350
[TBL] [Abstract][Full Text] [Related]
12. Pre-morbid body mass index and mortality after incident heart failure: the ARIC Study.
Khalid U; Ather S; Bavishi C; Chan W; Loehr LR; Wruck LM; Rosamond WD; Chang PP; Coresh J; Virani SS; Nambi V; Bozkurt B; Ballantyne CM; Deswal A
J Am Coll Cardiol; 2014 Dec; 64(25):2743-9. PubMed ID: 25541126
[TBL] [Abstract][Full Text] [Related]
13. Obesity, subclinical myocardial injury, and incident heart failure.
Ndumele CE; Coresh J; Lazo M; Hoogeveen RC; Blumenthal RS; Folsom AR; Selvin E; Ballantyne CM; Nambi V
JACC Heart Fail; 2014 Dec; 2(6):600-7. PubMed ID: 25443112
[TBL] [Abstract][Full Text] [Related]
14. Relationship between galectin-3 levels and mineralocorticoid receptor antagonist use in heart failure: analysis from HF-ACTION.
Fiuzat M; Schulte PJ; Felker M; Ahmad T; Neely M; Adams KF; Donahue MP; Kraus WE; Piña IL; Whellan DJ; O'Connor CM
J Card Fail; 2014 Jan; 20(1):38-44. PubMed ID: 24304938
[TBL] [Abstract][Full Text] [Related]
15. Adjusting for reverse causation to estimate the effect of obesity on mortality after incident heart failure in the Atherosclerosis Risk in Communities (ARIC) study.
Shakiba M; Soori H; Mansournia MA; Nazari SSH; Salimi Y
Epidemiol Health; 2016; 38():e2016025. PubMed ID: 27283142
[TBL] [Abstract][Full Text] [Related]
16. Plasma galectin-3 levels are associated with the risk of incident chronic kidney disease.
Rebholz CM; Selvin E; Liang M; Ballantyne CM; Hoogeveen RC; Aguilar D; McEvoy JW; Grams ME; Coresh J
Kidney Int; 2018 Jan; 93(1):252-259. PubMed ID: 28865675
[TBL] [Abstract][Full Text] [Related]
17. Galectin-3 and fibulin-1 in systolic heart failure - relation to glucose metabolism and left ventricular contractile reserve.
Holmager P; Egstrup M; Gustafsson I; Schou M; Dahl JS; Rasmussen LM; Møller JE; Tuxen C; Faber J; Kistorp C
BMC Cardiovasc Disord; 2017 Jan; 17(1):22. PubMed ID: 28068900
[TBL] [Abstract][Full Text] [Related]
18. Galectin-3 and the development of heart failure after acute coronary syndrome: pilot experience from PROVE IT-TIMI 22.
Grandin EW; Jarolim P; Murphy SA; Ritterova L; Cannon CP; Braunwald E; Morrow DA
Clin Chem; 2012 Jan; 58(1):267-73. PubMed ID: 22110019
[TBL] [Abstract][Full Text] [Related]
19. Association of Galectin-3 With Diabetes Mellitus in the Dallas Heart Study.
Vora A; de Lemos JA; Ayers C; Grodin JL; Lingvay I
J Clin Endocrinol Metab; 2019 Oct; 104(10):4449-4458. PubMed ID: 31162551
[TBL] [Abstract][Full Text] [Related]
20. Galectin-4 is associated with diabetes and obesity in a heart failure population.
Dieden A; Gudmundsson P; Korduner J; Molvin J; Zaghi A; Nezami Z; Bachus E; Holm H; Jujic A; Magnusson M
Sci Rep; 2023 Nov; 13(1):20285. PubMed ID: 37985679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
